EARNINGS: hVIVO CFO to retire; Personal Group sales and profit climb
15th Sep 2026 15:54
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 6.74p on 25-09-2026 at 06:50:01 |
|---|---|
| Change | 0.00p 0% |
| Buy | 6.90p |
| Sell | 6.30p |
| Last Trade: | Buy 816.00 at 6.74p |
| Day's Volume: | 0 |
| Last Close: | 6.74p |
| Open: | 0.00p |
| ISIN: | GB00B9275X97 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 4.35p - 10.00p |
| Market Capitalisation: | £46.40m |
| VWAP: | 0.00p |
| Shares in Issue: | 688.40m |
Sector: Health Care and Related Services
Listed In: FTSE AIM 100, FTSE AIM All-Share,
hVIVO (HVO) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 816 | 6.74p | Suspected BUY Trade |
16:35:25 - 24-Sep-26 |
| Sell* | 30,000 | 6.5755p | Ordinary |
16:23:42 - 24-Sep-26 |
| Sell* | 15,208 | 6.5755p | Ordinary |
15:58:12 - 24-Sep-26 |
| Sell* | 6,660 | 6.5755p | Ordinary |
15:53:35 - 24-Sep-26 |
| Sell* | 3,130 | 6.40p | SI Trade |
15:48:17 - 24-Sep-26 |
| Buy* | 5,000 | 6.80p | SI Trade |
15:48:17 - 24-Sep-26 |
| Buy* | 2,647 | 6.80p | SI Trade |
15:48:17 - 24-Sep-26 |
| Sell* | 109,251 | 6.5716p | Ordinary |
15:29:11 - 24-Sep-26 |
| Buy* | 10,000 | 6.6867p | Ordinary |
15:14:49 - 24-Sep-26 |
| Buy* | 10,000 | 6.6867p | Ordinary |
15:09:59 - 24-Sep-26 |
hVIVO (HVO) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Sep 2026 7:00 am | RNS | Board Changes |
| 15th Sep 2026 7:01 am | RNS | Interim Results |
| 15th Sep 2026 7:00 am | RNS | Chief Financial Officer Succession |
| 8th Sep 2026 3:51 pm | RNS | Holding(s) in Company |
| 4th Sep 2026 7:00 am | RNS | Notice of Results |
| 27th Aug 2026 7:00 am | RNS | hVIVO acquires CRS Berlin |
| 23rd Jul 2026 7:00 am | RNS | H1 2026 Trading Update |
| 13th Jul 2026 7:00 am | RNS | Change of Auditor |
| 9th Jun 2026 7:00 am | RNS | Holding(s) in Company |
| 1st Jun 2026 12:00 pm | RNS-R | Consultancy contract with Decoy Therapeutics |